The impact of quantitative imaging in medicine and surgery: Charting our course for the future
- PMID: 23256048
- PMCID: PMC3496488
- DOI: 10.3978/j.issn.2223-4292.2011.09.01
The impact of quantitative imaging in medicine and surgery: Charting our course for the future
Conflict of interest statement
No potential conflict of interest.
References
-
- Smith JJ, Sorensen AG, Thrall JH. Biomarkers in imaging: realizing radiology's future. Radiology. 2003;227:633–8. - PubMed
-
- Wang YX. Medical imaging in pharmaceutical clinical trials: what radiologists should know. Clin Radiol. 2005;60:1051–7. - PubMed
-
- Murphy PS, McCarthy TJ, Dzik-Jurasz AS. The role of clinical imaging in oncological drug development. Br J Radiol. 2008;81:685–92. - PubMed
-
- Morgan B, Thomas AL, Drevs J, et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol. 2003;21:3955–64. - PubMed
-
- Leach MO, Brindle KM, Evelhoch JL, et al. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol. 2003;76 Spec No 1:S87–91. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources